Thu, Jul 24, 2014, 10:15 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

blasedp31 62 posts  |  Last Activity: 13 hours ago Member since: Jan 16, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Is Insmed 30 days away or less before the FDA gives an answer? I would think patients would like to see it this week!

    [ The Company also intends to apply for Breakthrough Therapy Designation for ARIKAYCE in the United States based upon the culture conversion results. ARIKAYCE has already received Orphan Drug, Qualified Infectious Disease Product (QIDP) and Fast Track designations from the U.S. Food and Drug Administration ]

    [ The Secretary may approve an application for approval of a product for a serious or life-threatening disease ... upon a determination that the product has an effect on ... a clinical endpoint ... that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. ]

    ARIKAYCE converted 11 out of 44 patients suffering from drug-resistant pulmonary mycobacterial infections to culture-negative within twelve weeks - the majority within four weeks.

    1. Is conversion to culture-negative clinically significant?

    Yes - it warranted FDA approval of bedaquiline via the Breakthrough Therapy pathway.

    2. Could the FDA view efficacy in treating pulmonary infection by Non-tuberculous Mycobacteria as being "reasonably likely to predict" a clinical benefit in pulmonary infection by Mycobacterium Tuberculosis?

    a) In the treatment of MDR-TB, which currently requires the patient to suffer two years of systemic toxicity -

    In my opinion it would be reasonable to do so.

    b) In the treatment of normal TB, which currently requires the patient to suffer six months of systemic toxicity -

  • Reply to

    Pied PIpers says

    by terry_insm Apr 24, 2014 1:33 PM
    blasedp31 blasedp31 Apr 25, 2014 9:19 AM Flag

    Terry. You're FOS. Give us some FACTS that prove your suppositions. As always, NO Facts, just BS.

17.61-0.51(-2.81%)Jul 24 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Baidu, Inc.
NasdaqGSThu, Jul 24, 2014 4:00 PM EDT
Visa Inc.
NYSEThu, Jul 24, 2014 4:00 PM EDT